Federated Hermes’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Buy |
915,458
+727,731
| +388% | +$2.82M | 0.01% | 813 |
|
|
2025
Q1 | $939K | Buy |
+187,727
| New | +$939K | ﹤0.01% | 1122 |
|
|
2024
Q1 | – | Sell |
-121
| Closed | -$1.36K | – | 2028 |
|
|
2023
Q4 | $1.36K | Sell |
121
-2,014
| -94% | -$22.7K | ﹤0.01% | 1954 |
|
|
2023
Q3 | $5.55K | Buy |
2,135
+1,927
| +926% | +$5.01K | ﹤0.01% | 1875 |
|
|
2023
Q2 | $734 | Sell |
208
-732
| -78% | -$2.58K | ﹤0.01% | 2037 |
|
|
2023
Q1 | $3.97K | Buy |
+940
| New | +$3.97K | ﹤0.01% | 1953 |
|
|
2020
Q1 | – | Sell |
-370
| Closed | -$1K | – | 2236 |
|
|
2019
Q4 | $1K | Buy |
370
+223
| +152% | +$603 | ﹤0.01% | 2061 |
|
|
2019
Q3 | $1K | Buy |
+147
| New | +$1K | ﹤0.01% | 2065 |
|